Michael Shetzline, CMO, SVP & Head of Drug Devt at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 4,439 shares at $9.11 ($40K) on 2021-02-26, disclosed to the SEC on 2021-03-02.
Scheduled sale ($40k) by CMO, SVP & Head of Drug Devt under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.11 | 1,398 | $13K | 31.5% |
| 2 | $9.11 | 3,041 | $28K | 68.5% |
| Total | $9.11 avg | 4,439 | $40K | 100% |
| Filing → |
| IRWD | SELL | 2024-05-22 | $208K | — | Filing → |
| IRWD | SELL | 2024-02-14 | $1.2M | — | Filing → |
| IRWD | SELL | 2023-05-24 | $209K | — | Filing → |